Human KLK14 PharmaGenie ELISA Kit (SBRS0811)

Kallikrein-related peptidase 14 (KLK14) is a trypsin-like serine protease studied in prostate and ovarian cancer biology, skin desquamation, and protease cascade signaling. The Assay Genie PharmaGenie ELISA Kit enables quantitative measurement of human KLK14, supporting biomarker discovery and pathway research.

This in vitro immunoassay is supplied as a complete kit configured for 96 assays and uses an absorbance-based readout. Validated for human KLK14 reactivity, it accepts cell culture supernatants as well as plasma or serum specimens, giving flexibility across cell-based and clinical workflows in oncology, dermatology, and inflammation research.

Reconstituted reagents should be stored refrigerated, and the assay is intended for research use only. Researchers investigating KLK14 expression in tumor microenvironments, hormonal regulation, or skin barrier function can apply this kit to expression profiling and inhibitor screening studies.